Gilead Sciences

Facebook supports rewriting Section 230, and it’s starting to lay out the changes it wants. That’s the big takeaway from a nearly four-hour grilling of Facebook CEO Mark Zuckerberg, Alphabet CEO Sundar Pichai, and Twitter CEO Jack Dorsey. The point was quickly lost in a pre-election political scuffle — but in the coming months, it’ll be one of the most important things to watch.

A U.S. Senate hearing to reform an internet law and hold tech companies accountable for how they moderate content quickly turned into a political scuffle as lawmakers not only went after the companies but also attacked each other.

Against earlier disapproval by the World Health Organisation, the U.S. Food and Drug Administration approved remdesivir for the treatment of coronavirus infection.

Oil prices edged up on Thursday, but held near multi-week lows hit overnight after U.S. data showed gasoline demand fell and recovery from the COVID-19 pandemic was lagging.

A drug treatment that appears to shorten recovery time for people with coronavirus is being made available on the NHS.

The experimental drug remdesivir has been authorized by US regulators for emergency use against COVID-19, President Donald Trump announced Friday.

Gilead Sciences's remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year. Having a treatment could have a profound effect on the global pandemic, especially because health officials say any vaccine is likely a year or more away.

The experimental antiviral drug remdesivir has failed in its first randomized clinical trial to treat the COVID-19 illness, reports said Thursday, quoting draft documents that were accidentally published by the World Health Organization.

The trial comes after US health officials said last week they had started a trial to evaluate a possible vaccine in Seattle.

A U.S. biomedical firm has announced it will begin additional clinical trials of remdesivir, so far the most promising potential drug for coronavirus, with clinical trials involving about 1,000 patients starting in March.

As doctors scramble to contain the fast-spreading coronavirus, a potent brew of anti-retroviral and flu drugs has emerged as a possible defence against the mysterious sickness that has killed hundreds.

The Federal Government has stated its determination to develop world-class Special Economic Zones (SEZs) in each of the six geo-political regions of the country.

Key foreign investors, who met at various meetings with the Nigerian government delegation to the United Nation’s General Assembly in New York during the week, have expressed interest in scaling up investment in Nigeria.

Democratic Republic of Congo has approved four more experimental treatments against the deadly Ebola virus, the health ministry said as it raced to contain an outbreak in its violence-torn east.